Machida, Japan

Emi Shoji


 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 67(Granted Patents)


Location History:

  • Machida, JP (2006 - 2012)
  • Tokyo, JP (2014)

Company Filing History:


Years Active: 2006-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Emi Shoji: Innovator in Antibody Research

Introduction

Emi Shoji is a prominent inventor based in Machida, Japan, known for her significant contributions to the field of antibody research. With a total of four patents to her name, she has made remarkable strides in developing therapeutic and diagnostic agents for various immune diseases and blood cancers.

Latest Patents

Emi Shoji's latest patents include a method for producing recombinant antibodies and antibody fragments that specifically react with the extracellular domain of human CCR4. These patents encompass a DNA sequence encoding the recombinant antibody, methods for producing the antibody, and techniques for immunologically detecting CCR4. Additionally, her work includes methods for depleting cells expressing CCR4 on their surface and inhibiting the production of Th2 cytokines. These innovations aim to provide therapeutic and diagnostic solutions for Th2-mediated immune diseases and blood cancers.

Career Highlights

Throughout her career, Emi Shoji has worked with notable companies such as Kyowa Hakko Kirin Co., Limited and Kyowa Hakko Kogyo Co., Ltd. Her expertise in antibody research has positioned her as a key figure in the development of innovative treatments in the medical field.

Collaborations

Emi has collaborated with esteemed colleagues, including Kenya Shitara and Nobuo Hanai, to advance her research and contribute to the scientific community.

Conclusion

Emi Shoji's work in antibody research exemplifies her dedication to innovation and her impact on therapeutic advancements. Her patents and collaborations highlight her role as a leading inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…